Protein levels for occludin were down regulated in the prostate cancer cells CAHPV-10 (−2.8 fold), DU145 (−1.6 fold) and PC-3 (−9.3 fold) but up-regulated in LNCaP (2.4 fold) compared to PNT2. The gene discussed is OCLN; the disease is prostate carcinoma.